nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—CYP3A4—chronic kidney failure	0.359	0.546	CbGaD
Dabrafenib—ABCB1—chronic kidney failure	0.299	0.454	CbGaD
Dabrafenib—SLC22A8—nephron—chronic kidney failure	0.00547	0.0696	CbGeAlD
Dabrafenib—SLC22A8—urine—chronic kidney failure	0.00439	0.0558	CbGeAlD
Dabrafenib—LIMK1—blood—chronic kidney failure	0.0035	0.0446	CbGeAlD
Dabrafenib—SLCO1B1—blood plasma—chronic kidney failure	0.00295	0.0375	CbGeAlD
Dabrafenib—SIK1—nephron tubule—chronic kidney failure	0.00255	0.0325	CbGeAlD
Dabrafenib—SIK1—renal system—chronic kidney failure	0.00232	0.0295	CbGeAlD
Dabrafenib—SIK1—urethra—chronic kidney failure	0.00228	0.029	CbGeAlD
Dabrafenib—SIK1—kidney—chronic kidney failure	0.00224	0.0285	CbGeAlD
Dabrafenib—SIK1—cortex of kidney—chronic kidney failure	0.00218	0.0278	CbGeAlD
Dabrafenib—CYP3A4—urine—chronic kidney failure	0.00217	0.0277	CbGeAlD
Dabrafenib—BRAF—blood—chronic kidney failure	0.00217	0.0276	CbGeAlD
Dabrafenib—SIK1—gonad—chronic kidney failure	0.00208	0.0265	CbGeAlD
Dabrafenib—RAF1—nephron tubule—chronic kidney failure	0.00203	0.0259	CbGeAlD
Dabrafenib—SLC22A6—nephron tubule—chronic kidney failure	0.00197	0.0251	CbGeAlD
Dabrafenib—RAF1—renal system—chronic kidney failure	0.00185	0.0235	CbGeAlD
Dabrafenib—RAF1—cardiovascular system—chronic kidney failure	0.00182	0.0232	CbGeAlD
Dabrafenib—RAF1—urethra—chronic kidney failure	0.00181	0.0231	CbGeAlD
Dabrafenib—SIK1—blood—chronic kidney failure	0.00181	0.0231	CbGeAlD
Dabrafenib—RAF1—kidney—chronic kidney failure	0.00178	0.0227	CbGeAlD
Dabrafenib—RAF1—cortex of kidney—chronic kidney failure	0.00174	0.0221	CbGeAlD
Dabrafenib—SLC22A6—cortex of kidney—chronic kidney failure	0.00169	0.0215	CbGeAlD
Dabrafenib—CYP2C8—blood plasma—chronic kidney failure	0.00168	0.0213	CbGeAlD
Dabrafenib—RAF1—gonad—chronic kidney failure	0.00166	0.0211	CbGeAlD
Dabrafenib—RAF1—digestive system—chronic kidney failure	0.00151	0.0193	CbGeAlD
Dabrafenib—RAF1—blood—chronic kidney failure	0.00144	0.0184	CbGeAlD
Dabrafenib—SLCO1B1—renal system—chronic kidney failure	0.00138	0.0176	CbGeAlD
Dabrafenib—SLCO1B1—kidney—chronic kidney failure	0.00134	0.017	CbGeAlD
Dabrafenib—SLC22A8—nephron tubule—chronic kidney failure	0.00118	0.015	CbGeAlD
Dabrafenib—CYP3A4—blood plasma—chronic kidney failure	0.00113	0.0144	CbGeAlD
Dabrafenib—SLCO1B1—digestive system—chronic kidney failure	0.00113	0.0144	CbGeAlD
Dabrafenib—SLCO1B1—blood—chronic kidney failure	0.00108	0.0137	CbGeAlD
Dabrafenib—SLC22A8—renal system—chronic kidney failure	0.00107	0.0137	CbGeAlD
Dabrafenib—SLC22A8—kidney—chronic kidney failure	0.00104	0.0132	CbGeAlD
Dabrafenib—SLC22A8—cortex of kidney—chronic kidney failure	0.00101	0.0129	CbGeAlD
Dabrafenib—ABCG2—nephron tubule—chronic kidney failure	0.00084	0.0107	CbGeAlD
Dabrafenib—SLC22A8—blood—chronic kidney failure	0.000839	0.0107	CbGeAlD
Dabrafenib—ABCB1—blood plasma—chronic kidney failure	0.000803	0.0102	CbGeAlD
Dabrafenib—CYP2C8—renal system—chronic kidney failure	0.000785	0.01	CbGeAlD
Dabrafenib—CYP2C8—kidney—chronic kidney failure	0.000759	0.00967	CbGeAlD
Dabrafenib—ABCG2—urethra—chronic kidney failure	0.00075	0.00955	CbGeAlD
Dabrafenib—CYP2C8—blood—chronic kidney failure	0.000614	0.00781	CbGeAlD
Dabrafenib—ABCG2—blood—chronic kidney failure	0.000597	0.0076	CbGeAlD
Dabrafenib—CYP3A4—renal system—chronic kidney failure	0.000532	0.00677	CbGeAlD
Dabrafenib—CYP3A4—kidney—chronic kidney failure	0.000514	0.00655	CbGeAlD
Dabrafenib—CYP3A4—digestive system—chronic kidney failure	0.000436	0.00556	CbGeAlD
Dabrafenib—CYP3A4—blood—chronic kidney failure	0.000416	0.00529	CbGeAlD
Dabrafenib—ABCB1—nephron tubule—chronic kidney failure	0.000414	0.00527	CbGeAlD
Dabrafenib—ABCB1—renal system—chronic kidney failure	0.000377	0.00479	CbGeAlD
Dabrafenib—ABCB1—cardiovascular system—chronic kidney failure	0.000372	0.00474	CbGeAlD
Dabrafenib—ABCB1—urethra—chronic kidney failure	0.00037	0.00471	CbGeAlD
Dabrafenib—ABCB1—kidney—chronic kidney failure	0.000364	0.00463	CbGeAlD
Dabrafenib—ABCB1—cortex of kidney—chronic kidney failure	0.000355	0.00451	CbGeAlD
Dabrafenib—ABCB1—gonad—chronic kidney failure	0.000338	0.0043	CbGeAlD
Dabrafenib—ABCB1—digestive system—chronic kidney failure	0.000309	0.00393	CbGeAlD
Dabrafenib—ABCB1—blood—chronic kidney failure	0.000294	0.00375	CbGeAlD
Dabrafenib—ABCG2—Metabolism—SCARB1—chronic kidney failure	2.48e-05	9.39e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.47e-05	9.39e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—FASN—chronic kidney failure	2.47e-05	9.37e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—RELA—chronic kidney failure	2.46e-05	9.33e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—AVP—chronic kidney failure	2.45e-05	9.31e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS1—chronic kidney failure	2.45e-05	9.3e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCR5—chronic kidney failure	2.44e-05	9.28e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IRS1—chronic kidney failure	2.42e-05	9.18e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCG1—chronic kidney failure	2.41e-05	9.13e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SREBF1—chronic kidney failure	2.4e-05	9.12e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—DDC—chronic kidney failure	2.38e-05	9.05e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NCF1—chronic kidney failure	2.37e-05	9e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	2.37e-05	8.99e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MTHFR—chronic kidney failure	2.37e-05	8.98e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—RELA—chronic kidney failure	2.36e-05	8.96e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PIP5K1B—chronic kidney failure	2.35e-05	8.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—NFKB1—chronic kidney failure	2.35e-05	8.91e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NPS—chronic kidney failure	2.35e-05	8.91e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—HMGCR—chronic kidney failure	2.34e-05	8.87e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EDN1—chronic kidney failure	2.33e-05	8.86e-05	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL6—chronic kidney failure	2.32e-05	8.81e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PPARA—chronic kidney failure	2.32e-05	8.81e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL5—chronic kidney failure	2.32e-05	8.79e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRKAG2—chronic kidney failure	2.31e-05	8.78e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP2B6—chronic kidney failure	2.31e-05	8.78e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRKD1—chronic kidney failure	2.31e-05	8.78e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ARG2—chronic kidney failure	2.31e-05	8.75e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—DRD1—chronic kidney failure	2.3e-05	8.74e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—chronic kidney failure	2.29e-05	8.7e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—chronic kidney failure	2.29e-05	8.7e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP3A4—chronic kidney failure	2.29e-05	8.68e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—FASN—chronic kidney failure	2.29e-05	8.68e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—chronic kidney failure	2.28e-05	8.66e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.28e-05	8.64e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.28e-05	8.64e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LPL—chronic kidney failure	2.27e-05	8.6e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LCAT—chronic kidney failure	2.26e-05	8.58e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCA1—chronic kidney failure	2.25e-05	8.54e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LPL—chronic kidney failure	2.24e-05	8.49e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CYBA—chronic kidney failure	2.23e-05	8.47e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.2e-05	8.35e-05	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—chronic kidney failure	2.19e-05	8.32e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SREBF2—chronic kidney failure	2.17e-05	8.22e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FABP1—chronic kidney failure	2.16e-05	8.21e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	2.15e-05	8.16e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NGF—chronic kidney failure	2.15e-05	8.14e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—VEGFA—chronic kidney failure	2.13e-05	8.09e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SERPINE1—chronic kidney failure	2.13e-05	8.07e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP3A4—chronic kidney failure	2.12e-05	8.04e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—F2—chronic kidney failure	2.1e-05	7.96e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCC3—chronic kidney failure	2.09e-05	7.94e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GCKR—chronic kidney failure	2.09e-05	7.94e-05	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—VEGFA—chronic kidney failure	2.09e-05	7.94e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCR5—chronic kidney failure	2.09e-05	7.92e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCA1—chronic kidney failure	2.08e-05	7.91e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—DDC—chronic kidney failure	2.08e-05	7.88e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—chronic kidney failure	2.08e-05	7.88e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—NFKB1—chronic kidney failure	2.07e-05	7.87e-05	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—chronic kidney failure	2.07e-05	7.84e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CCR5—chronic kidney failure	2.06e-05	7.82e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—AGXT—chronic kidney failure	2.05e-05	7.78e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GATM—chronic kidney failure	2.05e-05	7.78e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LPIN1—chronic kidney failure	2.05e-05	7.77e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—AVP—chronic kidney failure	2.04e-05	7.76e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—NOS3—chronic kidney failure	2.03e-05	7.71e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP2B6—chronic kidney failure	2.02e-05	7.65e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRKD1—chronic kidney failure	2.02e-05	7.65e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRKAG2—chronic kidney failure	2.02e-05	7.65e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MTHFR—chronic kidney failure	2.02e-05	7.65e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	2.01e-05	7.64e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP2C18—chronic kidney failure	2.01e-05	7.61e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LRP2—chronic kidney failure	2.01e-05	7.61e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—NFKB1—chronic kidney failure	1.99e-05	7.56e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	1.97e-05	7.49e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—HBEGF—chronic kidney failure	1.96e-05	7.43e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—chronic kidney failure	1.96e-05	7.43e-05	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—chronic kidney failure	1.92e-05	7.28e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—chronic kidney failure	1.91e-05	7.25e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—ICAM1—chronic kidney failure	1.91e-05	7.24e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CAT—chronic kidney failure	1.9e-05	7.23e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—chronic kidney failure	1.89e-05	7.18e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SREBF2—chronic kidney failure	1.89e-05	7.16e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ACAT1—chronic kidney failure	1.88e-05	7.12e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CCL2—chronic kidney failure	1.87e-05	7.09e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—chronic kidney failure	1.86e-05	7.05e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCB1—chronic kidney failure	1.85e-05	7.03e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	1.84e-05	6.99e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	1.83e-05	6.94e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—chronic kidney failure	1.83e-05	6.93e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GCKR—chronic kidney failure	1.82e-05	6.92e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCC3—chronic kidney failure	1.82e-05	6.92e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IRS1—chronic kidney failure	1.81e-05	6.88e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—KRAS—chronic kidney failure	1.81e-05	6.88e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—F2—chronic kidney failure	1.79e-05	6.79e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LPIN1—chronic kidney failure	1.78e-05	6.77e-05	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—KRAS—chronic kidney failure	1.78e-05	6.75e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—LPL—chronic kidney failure	1.77e-05	6.7e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CAT—chronic kidney failure	1.76e-05	6.69e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LRP2—chronic kidney failure	1.75e-05	6.63e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP2C18—chronic kidney failure	1.75e-05	6.63e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	1.74e-05	6.61e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—chronic kidney failure	1.73e-05	6.55e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCB1—chronic kidney failure	1.72e-05	6.51e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CPT1A—chronic kidney failure	1.71e-05	6.47e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—CYP1A1—chronic kidney failure	1.71e-05	6.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—AVP—chronic kidney failure	1.7e-05	6.44e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IRS1—chronic kidney failure	1.69e-05	6.43e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IRS1—chronic kidney failure	1.67e-05	6.35e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—PPARA—chronic kidney failure	1.67e-05	6.33e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP2C19—chronic kidney failure	1.66e-05	6.31e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LIPC—chronic kidney failure	1.66e-05	6.31e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—NOS3—chronic kidney failure	1.65e-05	6.26e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.64e-05	6.22e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—LPL—chronic kidney failure	1.63e-05	6.2e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—chronic kidney failure	1.63e-05	6.19e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EDN1—chronic kidney failure	1.62e-05	6.13e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL5—chronic kidney failure	1.6e-05	6.08e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—KRAS—chronic kidney failure	1.6e-05	6.07e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CCL2—chronic kidney failure	1.6e-05	6.06e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	1.59e-05	6.05e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MTHFR—chronic kidney failure	1.59e-05	6.03e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—CYP1A1—chronic kidney failure	1.58e-05	5.99e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IGF1—chronic kidney failure	1.57e-05	5.95e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LPL—chronic kidney failure	1.57e-05	5.95e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PPARA—chronic kidney failure	1.56e-05	5.92e-05	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—KRAS—chronic kidney failure	1.54e-05	5.83e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SCARB1—chronic kidney failure	1.54e-05	5.83e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS1—chronic kidney failure	1.52e-05	5.77e-05	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—chronic kidney failure	1.51e-05	5.73e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.5e-05	5.68e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SREBF1—chronic kidney failure	1.49e-05	5.66e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SERPINE1—chronic kidney failure	1.49e-05	5.65e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CPT1A—chronic kidney failure	1.49e-05	5.64e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NGF—chronic kidney failure	1.48e-05	5.63e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCG1—chronic kidney failure	1.48e-05	5.62e-05	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—chronic kidney failure	1.47e-05	5.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SERPINE1—chronic kidney failure	1.47e-05	5.59e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MTHFR—chronic kidney failure	1.47e-05	5.59e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—HMGCR—chronic kidney failure	1.45e-05	5.5e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	1.45e-05	5.5e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP2C19—chronic kidney failure	1.45e-05	5.5e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LIPC—chronic kidney failure	1.45e-05	5.5e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PPARA—chronic kidney failure	1.44e-05	5.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCR5—chronic kidney failure	1.44e-05	5.48e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—RELA—chronic kidney failure	1.43e-05	5.44e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NOS3—chronic kidney failure	1.42e-05	5.4e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ARG2—chronic kidney failure	1.42e-05	5.39e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—FASN—chronic kidney failure	1.42e-05	5.39e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—NOS3—chronic kidney failure	1.41e-05	5.33e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LCAT—chronic kidney failure	1.39e-05	5.29e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—chronic kidney failure	1.34e-05	5.1e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RELA—chronic kidney failure	1.34e-05	5.08e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SCARB1—chronic kidney failure	1.34e-05	5.08e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS1—chronic kidney failure	1.32e-05	5.03e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	1.32e-05	4.99e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.31e-05	4.96e-05	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—chronic kidney failure	1.3e-05	4.94e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SREBF1—chronic kidney failure	1.3e-05	4.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—chronic kidney failure	1.3e-05	4.92e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCA1—chronic kidney failure	1.29e-05	4.91e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—chronic kidney failure	1.29e-05	4.88e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—DDC—chronic kidney failure	1.28e-05	4.86e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—chronic kidney failure	1.27e-05	4.82e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—HMGCR—chronic kidney failure	1.26e-05	4.8e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—KRAS—chronic kidney failure	1.24e-05	4.72e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	1.24e-05	4.71e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	1.24e-05	4.71e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	1.24e-05	4.71e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	1.24e-05	4.7e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—F2—chronic kidney failure	1.24e-05	4.7e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—FASN—chronic kidney failure	1.24e-05	4.69e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—NFKB1—chronic kidney failure	1.21e-05	4.59e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—chronic kidney failure	1.18e-05	4.47e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IRS1—chronic kidney failure	1.17e-05	4.45e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	1.16e-05	4.41e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—chronic kidney failure	1.16e-05	4.4e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP3A4—chronic kidney failure	1.15e-05	4.35e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—NFKB1—chronic kidney failure	1.13e-05	4.28e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—chronic kidney failure	1.13e-05	4.28e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCA1—chronic kidney failure	1.13e-05	4.27e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GCKR—chronic kidney failure	1.12e-05	4.26e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	1.12e-05	4.26e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—NOS3—chronic kidney failure	1.11e-05	4.21e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CCL2—chronic kidney failure	1.1e-05	4.19e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	1.1e-05	4.17e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CAT—chronic kidney failure	1.09e-05	4.15e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF1—chronic kidney failure	1.09e-05	4.12e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LRP2—chronic kidney failure	1.08e-05	4.09e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	1.08e-05	4.09e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—chronic kidney failure	1.07e-05	4.07e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCB1—chronic kidney failure	1.06e-05	4.04e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SERPINE1—chronic kidney failure	1.03e-05	3.91e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—NOS3—chronic kidney failure	1.03e-05	3.9e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—VEGFA—chronic kidney failure	1.02e-05	3.89e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—KRAS—chronic kidney failure	1.02e-05	3.87e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LPL—chronic kidney failure	1.01e-05	3.85e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—chronic kidney failure	1.01e-05	3.85e-05	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—chronic kidney failure	1.01e-05	3.84e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NOS3—chronic kidney failure	9.84e-06	3.73e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	9.8e-06	3.72e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CAT—chronic kidney failure	9.54e-06	3.62e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—chronic kidney failure	9.41e-06	3.57e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—chronic kidney failure	9.39e-06	3.56e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—KRAS—chronic kidney failure	9.32e-06	3.54e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—chronic kidney failure	9.29e-06	3.53e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RELA—chronic kidney failure	9.26e-06	3.52e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	9.16e-06	3.47e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MTHFR—chronic kidney failure	9.14e-06	3.47e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PPARA—chronic kidney failure	8.96e-06	3.4e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LIPC—chronic kidney failure	8.92e-06	3.39e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	8.92e-06	3.39e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LPL—chronic kidney failure	8.84e-06	3.35e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—KRAS—chronic kidney failure	8.71e-06	3.31e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—KRAS—chronic kidney failure	8.61e-06	3.27e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—CYP1A1—chronic kidney failure	8.54e-06	3.24e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—chronic kidney failure	8.3e-06	3.15e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	8.25e-06	3.13e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	8.16e-06	3.1e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	8e-06	3.04e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MTHFR—chronic kidney failure	7.96e-06	3.02e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—NFKB1—chronic kidney failure	7.81e-06	2.96e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PPARA—chronic kidney failure	7.81e-06	2.96e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	7.79e-06	2.95e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FASN—chronic kidney failure	7.62e-06	2.89e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—chronic kidney failure	7.59e-06	2.88e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—chronic kidney failure	7.31e-06	2.77e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—VEGFA—chronic kidney failure	7.09e-06	2.69e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—chronic kidney failure	7.09e-06	2.69e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—chronic kidney failure	7e-06	2.66e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	6.94e-06	2.63e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—chronic kidney failure	6.66e-06	2.53e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—chronic kidney failure	6.51e-06	2.47e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—NOS3—chronic kidney failure	6.37e-06	2.42e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—chronic kidney failure	6.36e-06	2.42e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—KRAS—chronic kidney failure	6.03e-06	2.29e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CAT—chronic kidney failure	5.88e-06	2.23e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—chronic kidney failure	5.83e-06	2.21e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—chronic kidney failure	5.8e-06	2.2e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	5.72e-06	2.17e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—NOS3—chronic kidney failure	5.55e-06	2.11e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LPL—chronic kidney failure	5.45e-06	2.07e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	5.26e-06	2e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—chronic kidney failure	5.08e-06	1.93e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—chronic kidney failure	4.9e-06	1.86e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	4.9e-06	1.86e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PPARA—chronic kidney failure	4.81e-06	1.83e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—chronic kidney failure	3.92e-06	1.49e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—chronic kidney failure	3.58e-06	1.36e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—NOS3—chronic kidney failure	3.42e-06	1.3e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	3.13e-06	1.19e-05	CbGpPWpGaD
